Overview

A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1018 and Coadministration of BR1018A and BR1018B in Healthy Adult Volunteers

Status:
COMPLETED
Trial end date:
2025-07-23
Target enrollment:
Participant gender:
Summary
The purpose of this clinical study is to evaluate the pharmacokinetics and the safety after administration of BR1018 and coadministration of BR1018A and BR1018B in healthy volunteers
Phase:
PHASE1
Details
Lead Sponsor:
Boryung Pharmaceutical Co., Ltd